Effect of zinc oxide nanomaterials-induced oxidative stress on the p53 pathway

Biomaterials

Volumn 34, Issue 38, 2013, Pages 10133-10142

  Setyawati, Magdiel I ^a   Tay, Chor Yong ^a   Leong, David T ^a,b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Anti oxidative defense; Nanotoxicology; P53; Reactive oxygen species; Zinc oxide nanomaterials

Indexed keywords

ANTI-OXIDATIVE DEFENSE; NANOTOXICOLOGY; P53; REACTIVE OXYGEN SPECIES; ZINC OXIDE NANOMATERIALS;

CELL CULTURE; CELL DEATH; GENE EXPRESSION; NANOSTRUCTURED MATERIALS; OXYGEN;

ZINC OXIDE;

ALDH4A1 PROTEIN; GLUTATHIONE PEROXIDASE 1; MANGANESE SUPEROXIDE DISMUTASE; NANOMATERIAL; PROTEIN; PROTEIN P53; REACTIVE OXYGEN METABOLITE; SESN1 PROTEIN; SESN2 PROTEIN; TATA BINDING PROTEIN; UNCLASSIFIED DRUG; ZINC OXIDE;

ARTICLE; CELL DEATH; CELL STRAIN HCT116; CELL SURVIVAL; COLON MUCOSA; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY TEST; EPITHELIUM CELL; FIBROBLAST; GENE SILENCING; HOMEOSTASIS; HUMAN; HUMAN CELL; NEWBORN; OXIDATIVE STRESS; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTI-OXIDATIVE DEFENSE; NANOTOXICOLOGY; P53; REACTIVE OXYGEN SPECIES; ZINC OXIDE NANOMATERIALS;

CELL LINE; HUMANS; NANOSTRUCTURES; OXIDATIVE STRESS; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53; ZINC OXIDE;

EID: 84885372066     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.09.024     Document Type: Article

References (54)

1. Chen X., Mao S.S. Titanium dioxide nanomaterials: synthesis, properties, modifications, and applications. Chem Rev 2007, 107:2891-2959.
2. Chen D., Luo Z., Li N., Lee J.Y., Xie J., Lu J. Amphiphilic polymeric nanocarriers with luminescent gold nanoclusters for concurrent bioimaging and controlled drug release. Adv Funct Mater 2013, 23:4324-4331.
3. Zhang W., Meng J., Ji Y., Li X., Kong H., Wu X., et al. Inhibiting metastasis of breast cancer cells invitro using gold nanorod-siRNA delivery system. Nanoscale 2011, 3:3923-3932.
4. Zhang P., Chen L., Xu T., Liu H., Liu X., Meng J., et al. Programmable fractal nanostructured interfaces for specific recognition and electrochemical release of cancer cells. Adv Mater 2013, 25:3566-3570.
5. Dhar S., Murawala P., Shiras A., Pokharkar V., Prasad B.L. Gellan gum capped silver nanoparticle dispersions and hydrogels: cytotoxicity and invitro diffusion studies. Nanoscale 2012, 4:563-567.
6. Setyawati M.I., Fang W., Chia S.L., Leong D.T. Nanotoxicology of common metal oxide based nanomaterials: their ROS-y and non-ROS-y consequences. Asia Pac J Chem Eng 2013, 8:205-217.
7. Yuan X., Setyawati M.I., Tan A.S., Ong C.N., Leong D.T., Xie J.P. Highly luminescent silver nanoclusters with tunable emissions: cyclic reduction-decomposition synthesis and antimicrobial properties. NPG Asia Mater 2013, 5:e39. 10.1038/am.2013.3.
8. Zhao F., Zhao Y., Liu Y., Chang X., Chen C., Zhao Y. Cellular uptake, intracellular trafficking, and cytotoxicity of nanomaterials. Small 2011, 7:1322-1337.
9. 22 and its implication for de novo design of nanomedicine. Proc Natl Acad Sci U S A 2012, 109:15431-15436.
10. Shi H., Magaye R., Castranova V., Zhao J. Titanium dioxide nanoparticles: a review of current toxicological data. Part Fibre Toxicol 2013, 10:15.
11. García C.P., Sumbayev V., Gilliland D., Yasinska I.M., Gibbs B.F., Mehn D., et al. Microscopic analysis of the interaction of gold nanoparticles with cells of the innate immune system. Sci Rep 2013, 3:1326.
12. Setyawati M.I., Tay C.Y., Chia S.L., Goh S.L., Fang W., Neo M.J., et al. Titanium dioxide nanomaterials cause endothelial cell leakiness by disrupting the homophilic interaction of VE-cadherin. Nat Commun 2013, 4:1673. 10.1038/ncomms2655.
13. 2 nanoparticles. Biomaterials 2012, 33:886-896.
14. Mortensen L.J., Jatana S., Gelein R., De Benedetto A., De Mesy Bentley K.L., Beck L.A., et al. Quantification of quantum dot murine skin penetration with UVR barrier impairment. Nanotoxicology 2013, 10.3109/17435390.2012.741726.
15. Tay C.Y., Fang W., Setyawati M.I., Sum C.P., Xie J., Ng K.W., et al. Reciprocal response of human oral epithelial cells to internalized silica nanoparticles. Part Part Syst Char 2013, 30:784-793.
16. Park M.V., Neigh A.M., Vermeulen J.P., de la Fonteyne L.J., Verharen H.W., Briede J.J., et al. The effect of particle size on the cytotoxicity, inflammation, developmental toxicity and genotoxicity of silver nanoparticles. Biomaterials 2011, 32:9810-9817.
17. Setyawati M.I., Khoo P.K., Eng B.H., Xiong S., Zhao X., Das G.K., et al. Cytotoxic and genotoxic characterization of titanium dioxide, gadolinium oxide, and poly(lactic-co-glycolic acid) nanoparticles in human fibroblasts. JBiomed Mater Res A 2013, 101A:633-640.
18. Singh N., Manshian B., Jenkins G.J., Griffiths S.M., Williams P.M., Maffeis T.G., et al. NanoGenotoxicology: the DNA damaging potential of engineered nanomaterials. Biomaterials 2009, 30:3891-3914.
19. Ng K.W., Khoo S.P., Heng B.C., Setyawati M.I., Tan E.C., Zhao X., et al. The role of the tumor suppressor p53 pathway in the cellular DNA damage response to zinc oxide nanoparticles. Biomaterials 2011, 32:8218-8225.
20. Zhao Y., Howe J.L., Yu Z., Leong D.T., Chu J.J., Loo J.S., et al. Exposure to titanium dioxide nanoparticles induces autophagy in primary human keratinocytes. Small 2013, 9:387-392.
21. Li J.J., Hartono D., Ong C.N., Bay B.H., Yung L.Y. Autophagy and oxidative stress associated with gold nanoparticles. Biomaterials 2010, 31:5996-6003.
22. Zhang Y., Ferguson S.A., Watanabe F., Jones Y., Xu Y., Biris A.S., et al. Silver nanoparticles decrease body weight and locomotor activity in adult male rats. Small 2013, 9:1715-1720.
23. Shi M., Kwon H.S., Peng Z., Elder A., Yang H. Effects of surface chemistry on the generation of reactive oxygen species by copper nanoparticles. ACS Nano 2012, 6:2157-2164.
24. Nel A., Xia T., Madler L., Li N. Toxic potential of materials at the nanolevel. Science 2006, 311:622-627.
25. Wu Y.L., Putcha N., Ng K.W., Leong D.T., Lim C.T., Loo S.C., et al. Biophysical responses upon the interaction of nanomaterials with cellular interfaces. Acc Chem Res 2013, 46:782-791.
26. Soenen S.J., Rivera-Gil P., Montenegro J.M., Parak W.J., De Smedt S.C., Braeckmans K. Cellular toxicity of inorganic nanoparticles: common aspects and guidelines for improved nanotoxicity evaluation. Nano Today 2011, 6:446-465.
27. Lane D.P. p53, guardian of the genome. Nature 1992, 358:15-16.
28. Sablina A.A., Budanov A.V., Ilyinskaya G.V., Agapova L.S., Kravchenko J.E., Chumakov P.M. The antioxidant function of the p53 tumor suppressor. Nat Med 2005, 11:1306-1313.
29. Chin C.F., Tian Q., Setyawati M.I., Fang W.R., Tan E.S.Q., Leong D.T., et al. Tuning the activity of platinum(IV) anticancer complexes through asymmetric acylation. JMed Chem 2012, 55:7571-7582.
30. van der Deen M., Taipaleenmaki H., Zhang Y., Teplyuk N.M., Gupta A., Cinghu S., et al. MicroRNA-34c inversely couples the biological functions of the runt-related transcription factor RUNX2 and the tumor suppressor p53 in osteosarcoma. JBiol Chem 2013, 288:21307-21319.
31. Borrás C., Gómez-Cabrera M.C., Viña J. The dual role of p53: DNA protection and antioxidant. Free Radic Res 2011, 45:643-652.
32. Xu M.S., Fujita D., Kajiwara S., Minowa T., Li X.L., Takemura T., et al. Contribution of physicochemical characteristics of nano-oxides to cytotoxicity. Biomaterials 2010, 31:8022-8031.
33. Yang H., Liu C., Yang D., Zhang H., Xi Z. Comparative study of cytotoxicity, oxidative stress and genotoxicity induced by four typical nanomaterials: the role of particle size, shape and composition. JAppl Toxicol 2009, 29:69-78.
34. Yin H., Casey P.S., McCall M.J., Fenech M. Effects of surface chemistry on cytotoxicity, genotoxicity, and the generation of reactive oxygen species induced by ZnO nanoparticles. Langmuir 2010, 26:15399-15408.
35. 3 and ZnO nanoparticles. Nanotoxicology 2012, 6:837-846.
36. Wiogo H.T.R., Lim M., Bulmus V., Yun J., Amal R. Stabilization of magnetic iron oxide nanoparticles in biological media by fetal bovine serum (FBS). Langmuir 2011, 27:843-850.
37. Akhtar M.J., Ahamed M., Kumar S., Khan M.M., Ahmad J., Alrokayan S.A. Zinc oxide nanoparticles selectively induce apoptosis in human cancer cells through reactive oxygen species. Int J Nanomedicine 2012, 7:845-857.
38. 2 to a freshwater microalga (Pseudokirchneriella subcapitata): the importance of particle solubility. Environ Sci Technol 2007, 41:8484-8490.
39. 2+ dissolution inside lysosomes. Part Fibre Toxicol 2011, 8:1-16.
40. Zaveri T.D., Dolgova N.V., Chu B.H., Lee J., Wong J., Lele T.P., et al. Contributions of surface topography and cytotoxicity to the macrophage response to zinc oxide nanorods. Biomaterials 2010, 31:2999-3007.
41. Hirao A., Kong Y.Y., Matsuoka S., Wakeham A., Ruland J., Yoshida H., et al. DNA damage-induced activation of p53 by the checkpoint kinase Chk2. Science 2000, 287:1824-1827.
42. Shieh S.Y., Ikeda M., Taya Y., Prives C. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 1997, 91:325-334.
43. Offer H., Erez N., Zurer I., Tang X., Milyavsky M., Goldfinger N., et al. The onset of p53-dependent DNA repair or apoptosis is determined by the level of accumulated damaged DNA. Carcinogenesis 2002, 23:1025-1032.
44. Unger T., Sionov R.V., Moallem E., Yee C.L., Howley P.M., Oren M., et al. Mutations in serines 15 and 20 of human p53 impair its apoptotic activity. Oncogene 1999, 18:3205-3212.
45. Huang C.C., Aronstam R.S., Chen D.R., Huang Y.W. Oxidative stress, calcium homeostasis, and altered gene expression in human lung epithelial cells exposed to ZnO nanoparticles. Toxicol InVitro 2010, 24:45-55.
46. Reddel R.R., Ke Y., Gerwin B.I., McMenamin M.G., Lechner J.F., Su R.T., et al. Transformation of human bronchial epithelial cells by infection with SV40 or adenovirus-12 SV40 hybrid virus, or transfection via strontium phosphate coprecipitation with a plasmid containing SV40 early region genes. Cancer Res 1988, 48:1904-1909.
47. Halliwell B. Oxidative stress and cancer: have we moved forward?. Biochem J 2007, 401:1-11.
48. Kaeser M.D., Pebernard S., Iggo R.D. Regulation of p53 stability and function in HCT116 colon cancer cells. JBiol Chem 2004, 279:7598-7605.
49. Kim H., Kokkotou E., Na X., Rhee S.H., Moyer M.P., Pothoulakis C., et al. Clostridium difficile toxin A-induced colonocyte apoptosis involves p53-dependent p21(WAF1/CIP1) induction via p38 mitogen-activated protein kinase. Gastroenterology 2005, 129:1875-1888.
50. Rodrigues N.R., Rowan A., Smith M.E., Kerr I.B., Bodmer W.F., Gannon J.V., et al. p53 mutations in colorectal cancer. Proc Natl Acad Sci U S A 1990, 87:7555-7559.
51. Rodriguez R., Meuth M. Chk1 and p21 cooperate to prevent apoptosis during DNA replication fork stress. Mol Biol Cell 2006, 17:402-412.
52. Stolz A., Ertych N., Bastians H. Tumor suppressor CHK2: regulator of DNA damage response and mediator of chromosomal stability. Clin Cancer Res 2011, 17:401-405.
53. Li H., Balajee A.S., Su T., Cen B., Hei T.K., Weinstein I.B. The HINT1 tumor suppressor regulates both gamma-H2AX and ATM in response to DNA damage. JCell Biol 2008, 183:253-265.
54. Pavlidis P., Noble W.S. Matrix2png: a utility for visualizing matrix data. Bioinformatics 2003, 19:295-296.